missing translation for 'onlineSavingsMsg'
Learn More

ULBP-1 Antibody (13C8), Novus Biologicals™

Rabbit Monoclonal Antibody

£260.00 - £406.00

Specifications

Antigen ULBP-1
Clone 13C8
Dilution Western Blot 1:500-1:2000, ELISA
Applications Western Blot, ELISA
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30024911
View Documents
Novus Biologicals
NBP3-26263-50ul
50 μL
£260.00
50µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30031032
View Documents
Novus Biologicals
NBP3-26263-100ul
100 μL
£406.00
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

ULBP-1 Monoclonal antibody specifically detects ULBP-1 in Human samples. It is validated for Western Blot, ELISA
Specifications

Specifications

ULBP-1
Western Blot 1:500-1:2000, ELISA
Monoclonal
Purified
RUO
Human
ALCAN-beta, N2DL1, N2DL-1, NKG2D ligand 1, NKG2DL1, RAET1Ialcan-beta, Retinoic acid early transcript 1I, UL16 binding protein 1, UL16-binding protein 1
A synthesized peptide derived from Human ULBP-1 [UniProt Q9BZM6]
Primary
Store at -20 to -70C. Avoid freeze-thaw cycles.
13C8
Western Blot, ELISA
Unconjugated
Rabbit
Immunology
PBS, pH 7.4, 150mM NaCl and 50% glycerol
80329
IgG
Affinity purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.